Willingness to pay for drug abuse treatment: Results from a contingent valuation study in Taiwan

Health Policy

Volumn 82, Issue 2, 2007, Pages 251-262

  Tang, Chao Hsiun ^a   Liu, Jin Tan ^b   Chang, Ching Wen ^a   Chang, Wen Ying ^a  

^a TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

Contingent valuation methods; Economic evaluation; Health care financing; National Health Insurance; Substance abuse; Taiwan; Willingness to pay

Indexed keywords

ADULT; AGED; ARTICLE; CONTINGENT VALUATION; CONTROLLED STUDY; DRUG ABUSE; FEMALE; FINANCIAL MANAGEMENT; HEALTH INSURANCE; HEALTH PROGRAM; HEALTH SURVEY; HUMAN; INTERVIEW; MALE; MEDICAL FEE; QUESTIONNAIRE; TAIWAN; TAX; TELEPHONE;

ADULT; AGED; COST-BENEFIT ANALYSIS; FEMALE; FINANCING, PERSONAL; HUMANS; INTERVIEWS; MALE; MIDDLE AGED; NATIONAL HEALTH PROGRAMS; PUBLIC OPINION; QUESTIONNAIRES; SUBSTANCE-RELATED DISORDERS; TAIWAN;

EID: 34248664986     PISSN: 01688510     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.healthpol.2006.09.007     Document Type: Article

References (37)

1. United Nations on Drugs and Crime. World Drug Report. New York: United Nations Office on Drugs and Crime (UN Publication no. NCJ-E.04.XI.16); 2004.
2. Ministry of Justice. Annual Anti-Drug Abuse Report. Taipei, Taiwan: Ministry of Justice; 2000.
3. Nasir S. Combating drug abuse, law enforcement is necessary but not sufficient. The Jakarta Post; 2005.
4. Xie X., Rehrn J., Single E., Robson L., and Paul J. The economic costs of illicit drug use in Ontario, 1992. Health Economics 7 (1998) 81-85
5. Office of National Drug Control Policy. The Economic Costs of Drug Abuse in the United States, 1992-1998. Washington, DC: Office of National Drug Control Policy, Executive Office of the President (Publication no. NCJ-190636); 2001.
6. Mark T.L., Woody G.E., Juday T., and Kleber H.D. The economic costs of heroin addiction in the United States. Drug Alcohol Dependence 61 (2001) 195-206
7. Garcia-Altes A., Olle J.M., Antonanzas F., and Colom J. The social cost of illegal drug consumption in Spain. Addiction 97 (2000) 1145-1153
8. Johannesson M., Johansson P.O., Kristrom B., and Gerdtham U.G. Willingness to pay for antihypertensive therapy-further report. Journal of Health Economics 12 (1993) 95-108
9. Lee S.J., Neumann P.J., Churchill W.H., Cannon M.E., Weinstein M.C., and Johannesson M. Patients' willingness to pay for autologous blood donation. Health Policy 40 (1997) 1-12
10. Chiu L., Tang K.Y., Shyu W.C., and Chang T.P. The willingness of families caring for victims of stroke to pay for in-home respite care-results of a pilot study in Taiwan. Health Policy 46 (1999) 239-254
11. Zarkin G.A., Cates S.C., and Bala M.V. Estimating the willingness to pay for drug abuse treatment: a pilot study. Journal of Substance Abuse Treatment 18 (2000) 149-159
12. Wagner T.H., Hu T.W., Dueñas G.V., Kaplan C.P., Nguyen B.H., and Pasick R.J. Does willingness to pay very by race/ethnicity? An analysis using mammography among low-income women. Health Policy 58 (2001) 275-288
13. Lenert L.A. Use of willingness to pay to study values for pharmacotherapies for migraine headache. Medical Care 41 (2003) 299-308
14. Whynes D.K., Frew E., and Wolstenholme J.L. A comparison of two methods for eliciting contingent valuations of colorectal cancer screening. Journal of Health Economics 22 (2003) 555-574
15. Greenberg D., Bakhai A., Neumann P.J., and Cohen D.J. Willingness to pay for avoiding coronary restenosis and repeat revascularization: results from a contingent valuation study. Health Policy 70 (2004) 207-216
16. Eckerlund I., Johannesson M., Johansson P.O., Tambour M., and Zethraeus N. Value for money? A contingent valuation study of the optimal size of the Swedish health care budget. Health Policy 34 (1995) 135-143
17. Asenso-Okyere W.K., Osei-Akoto I., Anum A., and Appiah E.N. Willingness to pay for health insurance in a developing economy. A pilot study of the informal sector of Ghana using contingent valuation. Health Policy 42 (1997) 223-237
18. Dong H., Kouyate B., Cairns J., and Sauerborn R. Differential willingness of household heads to pay community-based health insurance premia for themselves and other household members. Health Policy and Planning 19 (2004) 120-126
19. Tohmo T. Economic value of a local museum: factors of willingness to pay. Journal of Socio-Economics 33 (2004) 229-240
20. Gyrd-Hansen D., and Slothuus U. The citizen's preferences for financing public health care: a Danish survey. International Journal of Health Care Finance and Economics 2 (2002) 25-36
21. Olsen J.A., and Donaldson C. Helicopters, hearts and hips: using willingness to pay to set priorities for public sector health care programmes. Social Science and Medicine 46 (1998) 1-12
22. Diener A., O'Brien B., and Gafni A. Health care contingent valuation studies: a review and classification of the literature. Health Economics 7 (1998) 313-326
23. Klose T. The contingent valuation method in health care. Health Policy 47 (1999) 97-123
24. Foreit J.R., and Fleischman Foreit K.G. The reliability and validity of willingness to pay surveys for reproductive health pricing decisions in developing countries. Health Policy 63 (2003) 37-47
25. Johannesson M., Jonsson B., and Borgquist L. Willingness to pay for antihypertensive therapy-results of a Swedish pilot study. Journal of Health Economics 10 (1991) 461-473
26. Frew E.J., Wolstenholme J.L., and Whynes D.K. Comparing wiliness-to-pay: bidding game format versus open-ended and payment scale formats. Health Policy 68 (2004) 289-298
27. Kartman B., Stalhammar N.O., and Johannesson M. Valuation of health changes with the contingent valuation method: a test of scope and question order effects. Health Economics 5 (1996) 531-541
28. Federick S., and Fischhoff B. Scope insensitivity in elicited valuations. Risk Decision Policy 3 (1998) 109-123
29. Norinder A., Hjalte K., and Persson U. Scope and scale insensitivities in a contingent valuation study of risk reductions. Health Policy 57 (2001) 141-153
30. Gerstein D.R., Johnson R.A., Harwood H.J., et al. Evaluating recovery services: the California drug and alcohol treatment assessment (CALDATA) general report (1994), Department of Alcohol and Drug Problems, California
31. Bureau of National Health Insurance. Statistics of the National Health Insurance in 2004. Taipei, Taiwan: Bureau of National Health Insurance, Department of Health, Executive Yuan; 2004.
32. Randall A., Grunewald O., Johnson S., Ausness R., and Pagoulatos A. Reclaiming coal surface mines in central Appalachia: a case study of the benefits and costs. Land Economics 54 (1978) 472-489
33. Daubert J.T., and Young R.A. Recreational demands for maintaining instream flows: a contingent valuation approach. American Journal of Agricultural Economics 63 (1981) 666-676
34. Greenley D.A., Walsh A.G., and Young R.A. Option value: empirical evidence from a case study of recreation and water quality. Quarterly Journal of Economics 95 (1981) 657-673
35. Gafni A. Using willingness-to-pay as a measure of benefits: what is the relevant question to ask in the context of public decision making?. Medical Care 29 (1991) 1246-1252
36. Day B, Mourato S. Willingness to pay for water quality maintenance in Chinese rivers. GSERGE Working Paper WM98-02. Norwich, UK: The Centre for Social and Economic Research on the Global Environment, the University of East Anglia; 1998.
37. National Oceanic and Atmosphere Administration. Report of the NOAA panel on contingent valuation. Federal Register 1993; 58:4602-4614.